Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants

Clinical trial NCT00290303 · COMPLETED

Trial details

NCT number: NCT00290303
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Haemophilus Influenzae Type b Diphtheria Whole Cell Pertussis Hepatitis B Tetanus

Start date: 2004-05-01
Primary completion: 2005-03-01
Enrollment: 996

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.